Schedule 13G ownership disclosure

CHINOOK THERAPEUTICS INC

Security class unavailable · CUSIP: 16961L106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,047,732
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-22-000556
Form type
SC 13G
Filer
CHINOOK THERAPEUTICS, INC.
CIK
CIK 1435049
Filed
Jun 07, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub